Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial

BACKGROUND: Due to increasing antimicrobial resistance, a bismuth-based quadruple regimen has been recommended as an alternative first-line therapy for Helicobacter pylori (H pylori) eradication. However, different results are varied greatly and the availability of bismuth was limited in some countr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Di, Ke, Li, Ni, Zhen, Chen, Yu, Zhang, Lin-Hui, Zhu, Shao-Hua, Li, Chan-Juan, Shang, Lei, Liang, Jie, Shi, Yong-Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556219/
https://www.ncbi.nlm.nih.gov/pubmed/28796053
http://dx.doi.org/10.1097/MD.0000000000007697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556219/
https://www.ncbi.nlm.nih.gov/pubmed/28796053
http://dx.doi.org/10.1097/MD.0000000000007697

Ejemplares similares